Cancer modeling and network biology: accelerating toward personalized medicine.

The complexity of cancer progression can manifests itself on at least three scales that can be described using mathematical models, namely microscopic, mesoscopic and macroscopic scales. Multiscale cancer models have proven to be advantageous in this context because they can simultaneously incorporate the many different characteristics and scales of complex diseases such as cancer. This has driven the expansion of more predictive data-driven models, coupled to experimental and clinical data. These models are defining the foundations that facilitate the forthcoming design of patient specific cancer therapy. This should be considered as a great leap toward the era of personalized medicine. Consequently, further improvements in mathematical modeling of cancer will lead to the design of more sophisticated cancer therapy approaches.

[1]  Maciej Swat,et al.  Systems oncology: towards patient-specific treatment regimes informed by multiscale mathematical modelling. , 2015, Seminars in cancer biology.

[2]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[3]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[4]  J. Gibbs Mechanism-based target identification and drug discovery in cancer research. , 2000, Science.

[5]  H. Kitano,et al.  Computational systems biology , 2002, Nature.

[6]  Philip Gerlee,et al.  Bridging scales in cancer progression: mapping genotype to phenotype using neural networks. , 2014, Seminars in cancer biology.

[7]  G. Mills,et al.  Future of personalized medicine in oncology: a systems biology approach. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. L. Martins,et al.  Multiscale models for the growth of avascular tumors , 2007 .

[9]  Z. Hall Cancer , 1906, The Hospital.

[10]  Joseph D Butner,et al.  Simulating cancer growth with multiscale agent-based modeling. , 2015, Seminars in cancer biology.

[11]  Osbaldo Resendis-Antonio,et al.  Modeling metabolism: a window toward a comprehensive interpretation of networks in cancer. , 2015, Seminars in cancer biology.

[12]  D. Scudiero,et al.  Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. , 1991, Journal of the National Cancer Institute.

[13]  H. Bolouri Network dynamics in the tumor microenvironment. , 2015, Seminars in cancer biology.

[14]  Ali Najafi,et al.  Seminars in Cancer Biology , 2014 .

[15]  O. Warburg On the origin of cancer cells. , 1956, Science.

[16]  Gary D Bader,et al.  Computational approaches to identify functional genetic variants in cancer genomes , 2013, Nature Methods.

[17]  Ali Masoudi-Nejad,et al.  Metabolic cancer biology: structural-based analysis of cancer as a metabolic disease, new sights and opportunities for disease treatment. , 2015, Seminars in cancer biology.

[18]  Ina Koch,et al.  Genome Scale Modeling in Systems Biology: Algorithms and Resources , 2014, Current genomics.

[19]  E. Wang,et al.  Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. , 2014, Seminars in cancer biology.

[20]  Daniel V. Veres,et al.  Cancer stem cells display extremely large evolvability: alternating plastic and rigid networks as a potential Mechanism: network models, novel therapeutic target strategies, and the contributions of hypoxia, inflammation and cellular senescence. , 2013, Seminars in cancer biology.